Clinical Trial Update: Postmarketing Surveillance Study to Assess Handling and Patient Satisfaction on Berodual® Respimat® Solution for Inhalation in Patients With Chronic Obstructive Pulmonary Disease

View source ↗

Summary

This postmarketing surveillance study assessed handling and patient satisfaction with Berodual Respimat inhalation solution in people with chronic obstructive p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Berodual Respimat (ipratropium bromide and fenoterol hydrobromide)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Status: COMPLETED